Related Experiment Video
Updated: Jul 15, 2025

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
297
Meta-Analysis of Rates and Risk Factors for Local Recurrence in Surgically Resected Patients With NSCLC and
John M Varlotto1, Cristina Bosetti2, Dwight Bronson3
1Department of Oncology, Edwards Comprehensive Cancer Center/Marshall University, Huntington, West Virginia.
JTO Clinical and Research Reports
|September 27, 2023
Summary
Locoregional recurrence (LR) after non-small cell lung cancer (NSCLC) surgery is influenced by factors like lymphovascular invasion and tumor stage. Asian populations show lower LR rates and mortality compared to non-Asian populations.
Area of Science:
- Oncology
- Thoracic Surgery
- Radiotherapy
Background:
- Postoperative radiotherapy (PORT) for non-small cell lung cancer (NSCLC) impacts local failure but not overall survival.
- Significant disparities in locoregional recurrence (LR) rates exist between studies, necessitating an investigation into risk factors and population differences.
Purpose of the Study:
- To conduct a meta-analysis evaluating risk factors for LR in NSCLC patients with pN0-N2 disease.
- To explore potential differences in LR risk between Asian (AP) and non-Asian populations (NAP).
Main Methods:
- Meta-analysis of 87 studies (56 high-quality) of curative NSCLC resection (pT0-N2) published between 2000-2021.
- Pooled relative risks (RR) and 5-year rate estimates were derived using random-effects models for identified risk factors.
Main Results:
- Significant LR risk factors included pN2 vs. pN0 disease (RR 3.01), lymphovascular invasion (RR 1.92), and advanced pT3-4 vs. pT1 stage (RR 1.86).
- High-quality studies identified lymphovascular invasion (RR 1.94), sublobar resection (RR 1.86), and pN1 vs. pN0 (RR 1.84) as key risks.
- Pooled 5-year LR rates were lower in AP (12.0%) than NAP (22.7%), with lower 5-year mortality in AP (24.3%) vs. NAP (45.9%).
Conclusions:
- High-quality evidence for pN2 disease as an LR risk factor is limited; LR appears lower in Asian populations.
- Prospective evaluation of LR factors is needed before further PORT assessment, as recurrence may not solely depend on nodal status.
- Differences in recurrence rates between Asian and non-Asian populations warrant further investigation, as do the impacts of modern therapies.
Related Concept Videos
Cancer Survival Analysis
380
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
380
Comparing the Survival Analysis of Two or More Groups
218
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
218

